Academic articles regarding COVID-19 from NCGM

Association of acute-to-chronic glycemic ratio and outcomes in patients with COVID-19 and undiagnosed diabetes mellitus: A retrospective nationwide cohort study. 

Uchihara M, Sugiyama T, Bouchi R, Matsunaga N, Asai Y, Gatanaga H, Ohsugi M, Ohmagari N, Kajio H, Ueki K.

J Diabetes Investig. 2023.
https://doi.org/10.1111/jdi.13979
2023/1/27

The Impact and Treatment of COVID-19 in Hemodialysis Patients. 

Katagiri D, Kikuchi K.
J. Clin. Med. 2023; 12(3):838.
https://doi.org/10.3390/jcm12030838
2023/1/20

Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma.

Inada M, Togano T, Terada M, Shiratori K, Tsuzuki S, Takamatsu Y, Saito S, Hangaishi A, Morioka S, Kutsuna S, Maeda K, Mitsuya H, Ohmagari N.
Transfus Apher Sci. 2022:103638.
https://doi.org/10.1016/j.transci.2022.103638
(2022/12/29)

A review of incidentally diagnosed COVID-19 in the emergency department.

Yamamoto H, Funato Y, Kobayashi K, Sasaki R, Kimura A.
KANTO Journal of Japanese Association for Acute Medicine. 2022; 43(4):101-106.
https://doi.org/10.24697/jaamkanto.43.4_101
(2022/12/28)

Regional trends in the use of steroids and favipiravir for COVID-19 treatment.

Asai Y, Tsuzuki S, Matsunaga N, Ohmagari N.
J Infect Public Health. 2022; 16(2):206-213.
https://doi.org/10.1016/j.jiph.2022.12.014
(2022/12/26)

Dyslipidemia and SARS-CoV-2 spike antibody titres after the second and third doses of the BNT162b2 vaccine among healthcare workers in Japan.

Islam Z, Yamamoto S, Mizoue T, Oshiro Y, Inamura N, Konishi M, Ozeki M, Sugiura W, Ohmagari N.
Diabetes Metab Res Rev. 2022:e3606.
https://doi.org/10.1002/dmrr.3606
(2022/12/23)

Towards the light at the end of the tunnel: Changes in clinical settings and political measures regarding COVID-19 from 2021, and future perspectives in Japan.

Kamegai K, Hayakawa K.
Glob Health Med. 2022.
https://doi.org/10.35772/ghm.2022.01071
(2022/12/17)

Challenges and the potential of promoting remote medical interpreting during COVID-19.

Saeki S, Iwata M, Tomizawa R, Minamitani K.
Glob Health Med. 2022.
https://doi.org/10.35772/ghm.2022.01056
(2022/12/15)

Association between γ-Glutamyl Transpeptidase and SARS-CoV-2 Spike Antibody Titers among BNT162b2 Vaccine Recipients.

Islam Z, Yamamoto S, Mizoue T, Oshiro Y, Inamura N, Nemoto T, Konishi M, Ozeki M, Sugiura W, Ohmagari N.
Vaccines. 2022; 10(12):2142.
https://doi.org/10.3390/vaccines10122142
(2022/12/14)

Comparison of the clinical characteristics and outcomes of Japanese patients with COVID-19 treated in primary, secondary, and tertiary care facilities.

Tomidokoro D, Asai Y, Hayakawa K, Kutsuna S, Terada M, Sugiura W, Ohmagari N, Hiroi Y.
J Infect Chemother. 2022:S1341-321X(22)00326-9.
https://doi.org/10.1016/j.jiac.2022.12.003
(2022/12/13)

Social contact patterns in Japan in the COVID-19 pandemic during and after the Tokyo Olympic Games.

Tsuzuki S, Asai Y, Ibuka Y, Nakaya T, Ohmagari N, Hens N, Beutels P.
J Glob Health. 2022; 12:05047.
https://doi.org/10.7189/jogh.12.05047
(2022/12/3)

Polymyxin B immobilized fiber column direct hemoperfusion for severe COVID 19

Katagiri D.
J Jpn Soc Blood Purif Crit Care. 2022; 13(1):52-53.
https://doi.org/10.34325/jsbpcc.13.1_52
(2022/12/1)

Visualization of aerosol spread using a smoke tester during tracheal intubation performed in an operating room.

Hattori K, Eriguchi A, Omori M, Nagata O.
GHM Open. 2022.
https://doi.org/10.35772/ghmo.2022.01007
(2022/11/28)

Gastrointestinal endoscopy trends in a designated hospital for specified infectious diseases in Japan during the dawn of the living with COVID-19 era.

Yokoi C, Yanai Y, Suzuki K, Akazawa N, Yamamoto N, Akiyama J.
Glob Health Med. 2022.
https://doi.org/10.35772/ghm.2022.01021
(2022/11/27)

Effectiveness of a third dose of COVID-19 mRNA vaccine during the Omicron BA.1- and BA.2-predominant periods in Japan: The VENUS Study.

Mimura W, Ishiguro C, Maeda M, Murata F, Fukuda H.
Open Forum Infect Dis.2022; ofac636.
https://doi.org/10.1093/ofid/ofac636
(2022/11/24)

Glycemic control using intermittently scanned continuous glucose monitoring in patients with diabetes requiring methylprednisolone therapy for severe COVID-19. 

Uchihara M, Kodani N, Bouchi R, Saito S, Miyazato Y, Sugimoto H, Umamoto K, Kobayashi M, Ihana-Sugiyama N, Ohsugi M, Tanabe A, Ueki K, Takasaki J, Hojo M, Kajio H.
Glob Health Med. 2022.
https://doi.org/10.35772/ghm.2022.01053
(2022/11/20)

Knowledge, attitude, perception, and factors associated with the risk perception of COVID-19 among nursing college students in Japanese universities: A cross-sectional study.

Shimotake Y, Mbelambela EPS, Muchanga SMJ, Villanueva AF, Siburian MD, Shimomoto R, Ikeuchi K, Matsunaga Y, Minami M, Iiyama T, Suganuma N.
Health Sci Rep. 2022; 5(6):e922.
https://doi.org/10.1002/hsr2.922
(2022/11/3)

Association between physical activity status and severity of COVID-19 in older adults.

Tsuzuki S, Akiyama T, Matsunaga N, Ohmagari N.

Epidemiol Infect. 2022:1-29.
https://doi.org/10.1017/s0950268822001686
(2022/11/3)

Generation of Angiotensin-Converting Enzyme 2/Transmembrane Protease Serine 2-Double-Positive Human Induced Pluripotent Stem Cell-Derived Spheroids for Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Drug Evaluation.

Higashi-Kuwata N, Yabe SG, Fukuda S, Nishida J, Tamura-Nakano M, Hattori SI, Okochi H, Mitsuya H.

Microbiol Spectr. 2022:e0349022.
https://doi.org/10.1128/spectrum.03490-22
(2022/10/31)

Oncology and cardiology positron emission tomography/computed tomography faced with COVID-19: A review of available literature data.

Minamimoto R.
Front. Med. 2022.
https://doi.org/10.3389/fmed.2022.1052921
(2022/10/29)

Liver resection in a patient with persistent positive PCR test for coronavirus disease 2019 (COVID-19): a case report.

Sugita A, Inagaki FF, Takemura N, Nakamura M, Ito K, Mihara F, Yamamoto K, Morioka S, Kokudo N.
Surg Case Rep. 2022; 8(1):200.
https://doi.org/10.1186/s40792-022-01553-z
(2022/10/20)

COVID-19 in Japan during 2020-2022: Characteristics, responses, and implications for the health care system.

Karako K, Song P, Chen Y, Karako T.
J Glob Health. 2022; 12:03073.
https://doi.org/10.7189/jogh.12.03073
(2022/10/14)

Metabolic syndrome and the immunogenicity of Pfizer-BioNTech vaccine: a cross-sectional study in Japanese healthcare workers.

Van Hoang D, Yamamoto S, Fukunaga A, Inoue Y, Mizoue T, Ohmagari N.
Diabetol Metab Syndr. 2022; 14(1):149.
https://doi.org/10.1186/s13098-022-00918-6
(2022/10/13)

SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG Response.

Takamatsu Y, Omata K, Shimizu Y, Kinoshita-Iwamoto N, Terada M, Suzuki T, Morioka S, Uemura Y, Ohmagari N, Maeda K, Mitsuya H.
Microbiol Spectr. 2022:e0271622.
https://doi.org/10.1128/spectrum.02716-22
(2022/10/11)

Acute myocardial infarction immediately after second vaccination for coronavirus disease 2019.

Kurozumi A, Hara H, Nagai R, Hiroi Y.
Clin Case Rep. 2022; 10(10):e6431.
https://doi.org/10.1002/ccr3.6431
(2022/10/11)

Effectiveness of messenger RNA vaccines against infection with SARS-CoV-2 during the periods of Delta and Omicron variant predominance in Japan: the Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.

Mimura W, Ishiguro C, Maeda M, Murata F, Fukuda H.
Int J Infect Dis. 2022; 125:58-60.
https://doi.org/10.1016/j.ijid.2022.10.001
(2022/10/8)

Dihydroceramide Δ4-Desaturase 1 Is Not Involved in SARS-CoV-2 Infection.

Hayashi Y, Matsuda K, Tanigawa K, Tanikawa T, Maeda K, Tsuchiya K.
Biol Pharm Bull. 2022; 45(10):1559-1563.
https://doi.org/10.1248/bpb.b22-00503
(2022/10/1)

Stroke treatment during the COVID-19 pandemic.

Tamai Y, Arai N, Fujitani M, Kanayama S, Inoue M, Hara T.
Glob Health Med. 2022.
https://doi.org/10.35772/ghm.2022.01028
(2022/9/30)

The role of clinical engineers in the coronavirus disease 2019 pandemic.

Sato M, Fukaya T, Ogawa T, Nunose N, Hosaka S.
Glob Health Med. 2022; 4(5):294-295.
https://doi.org/10.35772/ghm.2022.01012
(2022/9/26)

Efforts of a Psychiatric Liaison Team in a ward with patients with severe coronavirus disease 2019.

Sone H, Ogawa H, Miyaki R, Kato O.
Glob Health Med. 2022.
https://doi.org/10.35772/ghm.2022.01019
(2022/9/26)

The development of SARS-CoV-2 PCR testing methods at a designated medical institution for specific infectious diseases in Japan.

Motohashi A.
Glob Health Med. 2022.
https://doi.org/10.35772/ghm.2022.01010
(2022/9/26)

Loneliness and Increased Hazardous Alcohol Use: Data from a Nationwide Internet Survey with 1-Year Follow-Up.

Wakabayashi M, Sugiyama, Y, Takada, M, Kinjo, A, Iso, H, Tabuchi, T.
Int J Environ Res Public Health. 2022:19, 12086.
https://doi.org/10.3390/ijerph191912086
(2022/9/24)

Updated report of COVID-19 vaccine safety monitoring in Japan: Booster shots and paediatric vaccinations.

Yamaguchi T, Iwagami M, Ishiguro C, Fujii D, Yamamoto N, Sakai H, Tsuboi T, Umeda H, Kinoshita N, Iguchi T, Oka A, Morio T, Nakai K, Hayashi S, Tsuruta S.
Lancet Reg Health West Pac. 2022; 27:100600.
https://doi.org/10.1016/j.lanwpc.2022.100600
(2022/9/20)

SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2: a 9 months longitudinal study.

Takeuchi JS, Fukunaga A, Yamamoto S, Tanaka A, Matsuda K, Kimura M, Kamikawa A, Kito Y, Maeda K, Ueda G, Mizoue T, Ujiie M, Mitsuya H, Ohmagari N, Sugiura W.
Sci Rep. 2022; 12(1):15447.
https://doi.org/10.1038/s41598-022-19581-y
(2022/9/14)

An average of nearly 200,000 new infections per day over a six-week period: What is the impact of such a severe COVID-19 pandemic on the healthcare system in Japan?

Karako K, Song P, Chen Y, Karako T.
Biosci Trends. 2022.
https://doi.org/10.5582/bst.2022.01390
(2022/9/12)

Potential usage of anterior nasal sampling in clinical practice with three rapid antigen tests for SARS-CoV-2.

Nomoto H, Yamamoto K, Isaka E, Miyazato Y, Suzuki T, Maruki T, Yamada G, Kamegai K, Akiyama Y, Ide S, Kurokawa M, Moriya A, Mezaki K, Yagi S, Nojima H, Yamakawa K, Ohmagari N.
J Infect Chemother. 2022:S1341-321X(22)00254-9.
https://doi.org/10.1016/j.jiac.2022.09.001
(2022/9/8)

An Autopsy Report of a Case with Cerebral Infarction Complicated by Coronavirus Disease 2019 Infection.

Goto R, Kawakami H, Horiuchi Y, Chikada A, Yasuda T, Suzuki T, Miyazato Y, Ishikane M, Kishino Y, Miyazaki H, Igari T, Katano H, Suzuki T, Murayama S, Arai N.
Intern Med. 2022.
https://doi.org/10.2169/internalmedicine.9726-22
(2022/9/6)

Antibody titers and neutralizing activity in cases of COVID-19 after a single dose of vaccination.

Okumura N, Saito S, Takamatsu Y, Takeuchi JS, Asai Y, Sanada M, Iwamoto N, Kenji M, Mitsuya H, Ohmagari N.
J Infect Chemother. 2022:S1341-321X(22)00252-5.
https://doi.org/10.1016/j.jiac.2022.08.026
(2022/9/5)

Critically ill patients with novel coronavirus infectious disease (COVID-19) are relatively hemodynamically stable in the acute phase: a single-centered, retrospective, observational study.

Funato Y, Matsuda W, Uemura T, Kobayashi K, Sasaki R, Okamoto T, Kimura A.
JJAAM. 2022; 33: 474-81.
https://doi.org/10.1002/jja2.12739
(2022/9/1)

The first case of a child infected with SARS-CoV-2 Omicron variant in Japan, December 2021.

Horigome A, Yamanaka J, Takasago S, Iwamoto N, Saito T, Shichino H.
Jpn J Infect Dis. 2022.
https://doi.org/10.7883/yoken.jjid.2021.896
(2022/8/31)

Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants.

Mizoue T, Yamamoto S, Konishi M, Oshiro Y, Inamura N, Nemoto T, Ozeki M, Horii K, Okudera K, Sugiyama H, Aoyanagi N, Sugiura W, Ohmagari N.
J Infect. 2022:S0163-4453(22)00480-7.
https://doi.org/10.1016/j.jinf.2022.08.015
(2022/8/26)

Living with school-age children and absence among staff of a tertiary hospital during the Omicron epidemic in Tokyo.

Yamamoto S, Mizoue N, Mizoue T, Konishi M, Horii K, Sugiyama H, Ohmagari N.
J Hosp Infect. 2022:S0195-6701(22)00257-2.
https://doi.org/10.1016/j.jhin.2022.08.003
(2022/8/26)

Infection prevention practices and its associated factors among hospital workers in a national medical center designated for COVID-19 in Tokyo, Japan.

Manandhar Shrestha R, Inoue Y, Fukunaga A, Hoang DV, Yamamoto S, Miki T, Konishi M, Ohmagari N, Mizoue T.
PLoS One. 2022; 17(8):e0272856.
https://doi.org/10.1371/journal.pone.0272856
(2022/8/11)

Post COVID-19 condition of the Omicron variant of SARS-CoV-2.

Morioka S, Tsuzuki S, Suzuki M, Terada M, Akashi M, Osanai Y, Kuge C, Sanada M, Tanaka K, Maruki T, Takahashi K, Saito S, Hayakawa K, Teruya K, Hojo M, Ohmagari N.
J Infect Chemother. 2022; 28(11):1546-1551.
https://doi.org/10.1016/j.jiac.2022.08.007
(2022/8/11)

Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants.

Amano M, Otsu S, Maeda K, Uemura Y, Shimizu Y, Omata K, Matsuoka M, Shimada S, Mitsuya H.
Sci Rep. 2022; 12(1):13524.
https://doi.org/10.1038/s41598-022-17071-9
(2022/8/8)

A novel anticoagulation treatment protocol using unfractionated heparin for coronavirus disease 2019 patients in Japan, 2022.

Sato L, Ishikane M, Okumura N, Iwamoto N, Hayakawa K, Iseki K, Hara H, Ohmagari N.
Glob Health Med. 2022.
https://doi.org/10.35772/ghm.2022.01030
(2022/8/6)

International technical cooperation to low- and middle-income countries during the COVID-19 pandemic. 

Tamura T, Inoue N, Murakami H.
Glob Health Med. 2022.
https://doi.org/10.35772/ghm.2022.01014
(2022/8/6)

Antibody responses and correlates after two and three doses of BNT162b2 COVID-19 vaccine. 

Yamamoto S, Tanaka A, Oshiro Y, Inamura N, Mizoue T, Ohmagari N; for SARS-CoV-2 Seroepidemiological Study among NCGM staff.
Infection. 2022.
https://doi.org/10.1007/s15010-022-01898-5
(2022/8/4)

Unmasking latent extrapulmonary tuberculosis with newly diagnosed HIV-1 infection in a COVID-19 patient with prolonged fever.

Hirata K, Watanabe K, Sasaki T, Yoshimasu T, Shimomura A, Ando N, Yanagawa Y, Mizushima D, Teruya K, Kikuchi Y, Oka S, Tsukada K.
Oxf Med Case Reports. 2022; 2022(7):omac079.
https://doi.org/10.1093/omcr/omac079
(2022/7/26)

We should pay more attention to sex differences to predict the risk of severe COVID-19: men have the same risk of worse prognosis as women more than 10 years older. 

Matsushita Y, Yokoyama T, Hayakawa K, Matsunaga N, Ohtsu H, Saito S, Terada M, Suzuki S, Morioka S, Kutsuna S, Tsuzuki S, Hara H, Kimura A, Ohmagari N.
J Epidemiol. 2022.
https://doi.org/10.2188/jea.JE20220056
(2022/7/16)

Experience in dealing with COVID-19 pandemic with original phasing in our hospital.

Ide S, Morioka S, Sugai K, Kimura A , Kajio Y, Ohmagari N, Sugiyama H.
J. J Disast. Med. 2022; 27(2):151-158.
https://doi.org/10.51028/jjdisatmed.27.2_151
(2022/7/13)

Enhancing hospital quality management and patient safety in Vietnam: a technical assistance project utilizing online solutions during COVID-19 pandemic.

Moriyama J, Ito T, Doi M, Seino K, Luong DH, Iwamoto A, Murakami H.
Trop Med Health. 2022; 50(1):45.
https://doi.org/10.1186/s41182-022-00435-2
(2022/7/12)

Prognostic impact of delta variant in COVID–19 patients requiring mechanical ventilation in comparison with other variants: a single center retrospective analysis.

Kato F, Sekihara K, Okamoto T, Iguma R, Kojimahara T, Uemura T, Kimura A.
Journal of Japanese Association for Acute Medicine. 2022; 33(7):291-298.
https://doi.org/10.1016/j.jiac.2020.05.002
（2022/7/5）

Use of heated tobacco products, moderate alcohol drinking, and anti-SARS-CoV-2 IgG antibody titers after BNT162b2 vaccination among Japanese healthcare workers.

Yamamoto S, Tanaka A, Ohmagari N, Yamaguchi K, Ishitsuka K, Morisaki N, Kojima M, Nishikimi A, Tokuda H, Inoue M, Tanaka S, Umezawa J, Okubo R, Nishimura K, Konishi M, Miyo K, Mizoue T.
Prev Med. 2022; 161:10.
https://doi.org/10.1016/j.ypmed.2022.107123
(2022/7/1)

Sinus cardiac arrest due to dexmedetomidine in patient with severe COVID-19.

Sugiyama M, Sekihara K, Okamoto T, Shigeno A, Shibasaki T, Fukuda Y, Wa A, Kimura A.
KANTO Journal of Japanese Association for Acute Medicine. 2022; 43(3):72-75.
https://doi.org/10.24697/jaamkanto.43.3_72
(2022/6/30)

Parenting, Social Isolation, and Loneliness Among New Parents During the COVID-19 Pandemic in Japan: A Pilot Study.

Nomura S, Kisugi N, Endo K, Omori T.
Asia Pac J Public Health. 2022:10105395221108594.
https://doi.org/10.1177/10105395221108594
(2022/6/30)

Protocol of an Exploratory Single-Arm Study to Evaluate the Safety and Immunogenicity of KD-414 as a Booster Vaccine for SARS-CoV-2 in Healthy Adults (KAPIVARA).

Terayama Y, Tomita N, Terada-Hirashima J, Uemura Y, Shimizu Y, Takeuchi JS, Takamatsu Y, Maeda K, Mikami A, Ujiie M, Sugiura W.
Life. 2022; 12(7):966.
https://doi.org/10.3390/life12070966
(2022/6/27)

The patient-centered diabetes management during the COVID-19 pandemic.

Kodani N, Ohsugi M.
Glob Health Med. 2022.
https://doi.org/10.35772/ghm.2022.01031
(2022/6/27)

COVID-19 vaccine hesitancy and vaccine passports: a cross-sectional conjoint experiment in Japan.

Okamoto S, Kamimura K, Komamura K.
BMJ Open. 2022; 12(6):e060829.
http://dx.doi.org/10.1136/bmjopen-2022-060829
(2022/6/16)

COVID-19 vaccine in the Pacific Islands related to COVAX Facility and bilateral assistance.

Wakabayashi M, Takahashi M, Iso H.
Journal of International Health. 2022; 37(2):51-68.
https://doi.org/10.11197/jaih.37.51
(2022/6/16)

Predictors of silent hypoxia in hospitalized patients with COVID-19 in Japan.

Hayakawa K, Morioka S, Asai Y, Tsuzuki S, Yamada G, Suzuki S, Matsunaga N, Ohmagari N.
J Infect Chemother. 2022:S1341-321X(22)00176-3.
https://doi.org/10.1016/j.jiac.2022.06.001
(2022/6/13)

Problem drinkers and high risk-taking behaviors under the stay-at-home policy of the COVID-19 emergency declaration.

Wakabayashi M, Takada M, Kinjo A, Sugiyama Y, Iso H, Tabuchi T.
BMC Public Health. 2022; 22(1):1173.
https://doi.org/10.1186/s12889-022-13331-5
(2022/6/13)

A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT).

Tomita N, Saito S, Terada-Hirashima J, Mikami A, Uemura Y, Kutsuna S, Nomoto H, Fujisawa K, Nagashima M, Terada M, Ashida S, Morioka S, Satake M, Hangaishi A, Togano T, Shiratori K, Takamatsu Y, Maeda K, Ohmagari N, Sugiura W, Mitsuya H.
Life. 2022; 12(6):856.
https://doi.org/10.3390/life12060856
(2022/6/8)

Responding to COVID-19: Establishing a nursing system that is appropriate for the new post-epidemic era.

Sato T.
Glob Health Med. 2022.
https://doi.org/10.35772/ghm.2022.01005
(2022/6/6)

State of emergency and human mobility during the COVID-19 pandemic in Japan.

Okamoto S.
J Transp Health. 2022:101405.
https://doi.org/10.1016/j.jth.2022.101405
(2022/6/6)

Evaluation of the representativeness of data in the COVID-19 Registry Japan during the first six waves of the epidemic.

Hayakawa K, Asai Y, Matsunaga N, Tsuzuki S, Terada M, Suzuki S, Kitajima K, Saito S, Ohmagari N.

https://doi.org/10.35772/ghm.2022.01033
Glob Health Med. 2022.
(2022/5/29)

Can global vaccine disparities be corrected by the COVID-19 Vaccine Global Access Facility?

Wakabayashi M, Iso H.
Japanese Bulletin of Social Psychiatry. 2022; 31:134-145.
(2022/5/25)

Factors associated with development and persistence of post-COVID conditions: A cross-sectional study.

Miyazato Y, Tsuzuki S, Morioka S, Terada M, Kutsuna S, Saito S, Shimanishi Y, Takahashi K, Sanada M, Akashi M, Kuge C, Osanai Y, Tanaka K, Suzuki M, Hayakawa K, Ohmagari N.
https://doi.org/10.1016/j.jiac.2022.04.025
J Infect Chemother. 2022:S1341-321X(22)00139-8.
(2022/5/17)

Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2.

Uraki R, Kiso M, Iida S, Imai M, Takashita E, Kuroda M, Halfmann PJ, Loeber S, Maemura T, Yamayoshi S, Fujisaki S, Wang Z, Ito M, Ujie M, Iwatsuki-Horimoto K, Furusawa Y, Wright R, Chong Z, Ozono S, Yasuhara A, Ueki H, Sakai-Tagawa Y, Li R, Liu Y, Larson D, Koga M, Tsutsumi T, Adachi E, Saito M, Yamamoto S, Hagihara M, Mitamura K, Sato T, Hojo M, Hattori SI, Maeda K, Valdez R; IASO study team, Okuda M, Murakami J, Duong C, Godbole S, Douek DC, Maeda K, Watanabe S, Gordon A, Ohmagari N, Yotsuyanagi H, Diamond MS, Hasegawa H, Mitsuya H, Suzuki T, Kawaoka Y.
https://doi.org/10.1038/s41586-022-04856-1
Nature. 2022.
(2022/5/16)

Investigation of the use of PCR testing prior to ship boarding to prevent the spread of SARS-CoV-2 from urban areas to less populated remote islands.

Terada-Hirashima J, Sugiura W, Shimizu Y, Tanaka Y, Uemura Y, Ishikane M, Kazuyama Y, Ikeda M, Wakabayashi K, Ohmagari N, Kimura M.
Glob Health Med. 2022.
https://doi.org/10.35772/ghm.2022.01008
(2022/5/14)

Association of Impaired Fasting Glucose and Diabetes with SARS-CoV-2 Spike Antibody Titers after the BNT162b2 Vaccine among Health Care Workers in a Tertiary Hospital in Japan.

Islam Z, Yamamoto S, Mizoue T, Tanaka A, Oshiro Y, Inamura N, Konishi M, Ozeki M, Sugiura W, Ohmagari N.
https://doi.org/10.3390/vaccines10050776
Vaccines (Basel). 2022; 10(5):776.
(2022/5/13)

Interferon lambda 3 in the early phase of coronavirus disease-19 can predict oxygen requirement.

Suzuki T, Iwamoto N, Tsuzuki S, Kakumoto Y, Suzuki M, Ashida S, Oshiro Y, Nemoto T, Kanda K, Okuhama A, Yamada G, Inada M, Sato L, Miyazato Y, Akiyama Y, Saito S, Morioka S, Ujiie M, Hayakawa K, Sugiyama M, Mizokami M, Kodama EN, Ohmagari N.
https://doi.org/10.1111/eci.13808
Eur J Clin Invest. 2022:e13808.
(2022/5/4)

How did the Tokyo Metropolitan Government respond to COVID-19?

Ohmagari N.
https://doi.org/10.35772/ghm.2022.01017
Glob Health Med. 2022; 4(2):67-70.
(2022/4/30)

A Fatal Breakthrough Coronavirus Disease 2019 Case Following Bendamustine-Rituximab Therapy.

Kamegai K, Iwamoto N, Togano T, Maeda K, Takamatsu Y, Miyazato Y, Ishikane M, Mizokami M, Sugiyama M, Iida S, Miyamoto S, Suzuki T, Ohmagari N.
https://doi.org/10.1016/j.ijid.2022.04.058
Int J Infect Dis. 2022:S1201-9712(22)00258-2.
(2022/4/30)

Factors Associated With Prolonged Psychological Distress Among Nurses and Physicians Engaged in COVID-19 Patient Care in Singapore and Japan.

Morioka S, Tan BH, Kikuchi H, Asai Y, Suzuki T, Ashida S, Kutsuna S, Saito S, Hayakawa K, Tan TT, Kodama E, Ohmagari N.
Front Psychiatry. 2022; 13:781796.
https://doi.org/10.3389/fpsyt.2022.781796
(2022/4/28)

Clinical information: collection, analysis, and challenges.

Ohmagari N.
https://doi.org/10.4091/iken.32-51
Journal of Health Care and Society. 2022; 32(1):5158.
(2022/4/28)

Comparison of cardiac function between acute and recovery phases in four moderate COVID-19 patients.

Yara T, Hayama H, Kawaguchi M, Hiroi T, Ozeki M.
https://doi.org/10.14932/jamt.21-86
Japanese Journal of Medical Technology. 2022; 71(2):362-368.
(2022/4/25)

Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan.

Okumura N, Tsuzuki S, Saito S, Hattori S, Takeuchi S. J, Saito T, Ujiie M, Hojo M, Iwamoto N, Sugiura W, Mitsuya H, Ohmagari N.
https://doi.org/10.1016/j.jiac.2022.04.018
Journal of Infection and Chemotherapy 2022.
(2022/4/22)

Perspectives on countermeasures against COVID-19 in the remote islands of Yaeyama region, Okinawa, Japan.

Kamegai K, Sakai T, Teruya S, Kuba K, Ohmagari N.
https://doi.org/10.35772/ghm.2022.01027
Glob Health Med. 2022.
(2022/4/13)

Reporting on the implementation to set up a "care and isolation facility" for mild COVID-19 cases in Tokyo. 

Akashi H, Kodoi H, Noda S, Tamura T, Baba H, Chinda E, Thandar MM, Naito K, Watanabe Y, Suzuki Y, Narita T, Shimazu T.
https://doi.org/10.35772/ghm.2022.01022
Glob Health Med. 2022.
(2022/4/9)

Impact of prioritized vaccinations for the elderly on the COVID-19 pandemic in Japan.

Yamamoto S, Mizoue TNomoto H, Hayakawa K, Ohmagari N.

https://doi.org/10.35772/ghm.2022.01015
Glob Health Med. 2022.
(2022/4/9)

Establishment of an emergency regulatory approval system in Japan in response to the COVID-19 pandemic and challenges in developing domestically produced vaccines. 

Ujiie M.
https://doi.org/10.35772/ghm.2022.01023
Glob Health Med. 2022.
(2022/4/9)

Promotion of proper use of anti-SARS-CoV-2 drugs and SARS-CoV-2 vaccines by hospital pharmacists and establishment of an adverse drug reaction reporting system.

Seto K, Ohashi Y, Masuda J, Terakado H.

https://doi.org/10.35772/ghm.2022.01024
Glob Health Med. 2022.
(2022/4/9)

Association between chronic physical conditions and depressive symptoms among hospital workers in a national medical institution designated for COVID-19 in Japan.

Fukunaga A, Inoue Y, Yamamoto S, Miki T, Hoang DV, Manandhar Shrestha R, Ishiwari H, Ishii M, Miyo K, Konishi M, Ohmagari N, Mizoue T.
https://doi.org/10.1371/journal.pone.0266260
PLoS One. 2022;17(4):e0266260.
(2022/4/7)

A preliminary analysis of the secondary sex ratio decline after the COVID-19 pandemic in Japan.

Inoue Y, Mizoue T.
Am J Hum Biol. 2022:eajhb.
https://doi.org/10.1002/ajhb.23750
(2022/4/6)

Long COVID: current status in Japan and knowledge about its molecular background.

Matsunaga A, Tsuzuki S, Morioka S, Ohmagari N, Ishizaka Y.
https://doi.org/10.35772/ghm.2022.01013
Glob Health Med. 2022.
(2022/4/6)

Change in cancer diagnosis during the COVID-19 pandemic: Trends estimated from FDG-PET/CT.

Minamimoto R, Hotta M, Okafuji T, Tsutui S, Tsukuda M, Nakayama H, Shida Y, Tajima T.
https://doi.org/10.35772/ghm.2022.01016
Glob Health Med. 2022.
(2022/3/31)

Evaluating the daily life of child and adolescent psychiatric outpatients during temporary school closure over COVID-19 pandemic: A singlecenter case-control study in Japan.

Sasaki Y, Sasaki S, Sunakawa H, Toguchi Y, Tanese S, Saito K, Shinohara R, Kurokouchi T, Sugimoto K, Itagaki K, Yoshida Y, Namekata S, Takahashi M, Harada I, Hakosima Y, Inazaki K, Yoshimura Y, Mizumoto Y, Okada T, Usam M. 
https://doi.org/10.35772/ghm.2022.01001
Glob Health Med. 2022.
(2022/3/31)

For safe and adequate blood purification therapy in severe COVID-19 - what we have learned so far.

Katagiri D.
https://doi.org/10.35772/ghm.2022.01004
Glob Health Med. 2022.
(2022/3/31)

Cardiovascular considerations during the COVID-19 pandemic: A focused review for practice in Japan.

Tomidokoro D, Hiroi Y. 
https://doi.org/10.35772/ghm.2022.01006
Glob Health Med. 2022.
(2022/3/31)

Safety monitoring of COVID-19 vaccines in Japan.

Yamaguchi T, Iwagami M, Ishiguro C, Fujii D, Yamamoto N, Narisawa M, Tsuboi T, Umeda H, Kinoshita N, Iguchi T, Noda T, Tsuruta S, Oka A, Morio T, Nakai K, Hayashi S.
https://doi.org/10.1016/j.lanwpc.2022.100442
Lancet Reg Health West Pac. 2022;23:100442.
(2022/3/29)

Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants.

Ueno M, Iwata-Yoshikawa N, Matsunaga A, Okamura T, Saito S, Ashida S, Yoshida I, Nagashima M, Asakura H, Yaoita Y, Suzuki J, Sadamasu K, Yoshimura K, Kutsuna S, Shiwa-Sudo N, Nagata N, Suzuki T, Suzuki A, Okamoto M, Kimura M, Ohmagari N, Miura R, Ishizaka Y.
https://doi.org/10.1016/j.antiviral.2022.105297
Antiviral Res. 2022;201:105297.
(2022/3/24)

COVID-19 mRNA vaccine-related interstitial lung disease: Two case reports and literature review.

So C, Izumi S, Ishida A, Hirakawa R, Kusaba Y, Hashimoto M, Ishii S, Miyazaki H, Iikura M, Hojo M.
https://doi.org/10.1002/rcr2.938
Respirol Case Rep. 2022;10(4):e0938.
(2022/3/23)

Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan.

Tsuzuki S, Hayakawa K, Doi Y, Shinozaki T, Uemura Y, Matsunaga N, Terada M, Suzuki S, Asai Y, Yamada G, Saito S, Shibata T, Kondo M, Izumi K, Hojo M, Mizoue T, Yokota K, Nakamura-Uchiyama F, Saito F, Sugiura W, Ohmagari N.
https://doi.org/10.1007/s40121-022-00617-9
Infect Dis Ther. 2022.
(2022/3/21)

Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19.

Miyazato Y, Yamamoto K, Nakaya Y, Morioka S, Takeuchi JS, Takamatsu Y, Maeda K, Kimura M, Sugiura W, Mitsuya H, Yano M, Ohmagari N.
https://doi.org/10.1016/j.jiac.2022.03.002
J Infect Chemother. 2022.
(2022/3/20)

Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine.

Yamamoto S, Fukunaga A, Tanaka A, Takeuchi JS, Inoue Y, Kimura M, Maeda K, Ueda G, Mizoue T, Ujiie M, Sugiura W, Ohmagari N.
https://doi.org/10.1016/j.vaccine.2022.02.052
Vaccine. 2022;40(13):1924-1927.
(2022/3/18)

Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection.

Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Iwamoto N, Ujiie M, Kutsuna S, Morioka S, Ishizaka Y, Mitsuya H, Ohmagari N.
https://doi.org/10.1016/j.ijid.2022.03.017
Int J Infect Dis. 2022.
(2022/3/16)

Clinical characteristics of the first three waves of hospitalised patients with COVID-19 in Japan prior to the widespread use of vaccination: a nationwide observational study.

Matsunaga N, Hayakawa K, Asai Y, Tsuzuki S, Terada M, Suzuki S, Ohtsu H, Kitajima K, Toyoda A, Suzuki K, Suzuki M, Saito S, Uemura Y, Shibata T, Kondo M, Nakamura-Uchiyama F, Yokota K, Saito F, Izumi K, Sugiura W, Ohmagari N.
https://doi.org/10.1016/j.lanwpc.2022.100421
Lancet Reg Health West Pac. 2022;22:100421.
(2022/3/16)

Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.

Takahashi K, Ishikane M, Ujiie M, Iwamoto N, Okumura N, Sato T, Nagashima M, Moriya A, Suzuki M, Hojo M, Kanno T, Saito S, Miyamoto S, Ainai A, Tobiume M, Arashiro T, Fujimoto T, Saito T, Yamato M, Suzuki T, Ohmagari N. 
https://wwwnc.cdc.gov/eid/article/28/5/22-0197_article
Emerg Infect Dis. 2022;28(5):998-1001.
(2022/3/15)

Genetic association of IL17 and the importance of ABO blood group antigens in saliva to COVID-19.

Nishida N, Sugiyama M, Kawai Y, Naka I, Iwamoto N, Suzuki T, Suzuki M, Miyazato Y, Suzuki S, Izumi S, Hojo M, Tsuchiura T, Ishikawa M, Ohashi J, Ohmagari N, Tokunaga K, Mizokami M. 
https://doi.org/10.1038/s41598-022-07856-3
Sci Rep. 2022;12(1):3854.
(2022/3/9)

Fasciitis of the lower leg after COVID-19 vaccination.

Ide S, Kurozumi A, Takeshige A, Shimomura A, Watanabe R, Inagaki T.
Fasciitis of the lower leg after COVID-19 vaccination.
https://doi.org/10.1016/j.idcr.2022.e01475
IDCases. 2022;28:e01475. 
(2022/3/5)

Poor prognosis of patients with severe COVID-19 admitted to an infectious disease intensive care unit during the pandemic caused by the Delta variant in Japan.

Sekihara K, Shibasaki T, Okamoto T, Matsumoto C, Ito K, Fujimoto K, Kato F, Matsuda W, Kobayashi K, Sasaki R, Uemura T, Kimura A, Sugiyama H, Kokudo N.

https://doi.org/10.35772/ghm.2021.01121
Glob Health Med. 2022.
(2022/3/5)

When should polymyxin B-immobilized polystyrene column be introduced to improve COVID-19 prognosis?

Katagiri D, Izumi S, Takano H.
https://onlinelibrary.wiley.com/doi/10.1111/1744-9987.13825
Ther Apher Dial. 2022.
(2022/3/5)

Evaluation of the detection of other pathogens in hospitalized patients with COVID-19 at a tertiary hospital in Japan.

Suzuki M, Hayakawa K, Asai Y, Matsunaga N, Terada M, Ohtsu H, Toyoda A, Takasaki J, Hojo M, Yanagawa Y, Saito S, Yamamoto K, Ide S, Akiyama Y, Suzuki T, Moriya A, Mezaki K, Ohmagari N.
https://doi.org/10.7883/yoken.JJID.2021.232
Jpn J Infect Dis. 2022.
(2022/2/28)

Sex–associated differences between body mass index and SARS-CoV-2 antibody titers following the BNT162b2 vaccine.

Yamamoto S, Mizoue T, Tanaka A, Oshiro Y, Inamura N, Konishi M, Ozeki M, Miyo K, Sugiura W, Sugiyama H, Ohmagari N.
https://doi.org/10.1002/oby.23417
Obesity (Silver Spring). 2022
(2022/2/28)

Global extension of Japanese medical products related to COVID-19: a survey of WHO Emergency Use Listing.

Wakabayashi M, Ichimura Y, Shimizu E, Nishioka T, Kono Y, Doi M, Egami Y, Kadowaki T, Iso H, Fujita N.
https://doi.org/10.35772/ghmo.2021.01032
GHM open. 2022.
(2022/2/26)

Threatened abortion, threatened premature labor, and preterm birth during the first state of emergency for COVID-19 in 2020 in Japan.

Okawa S, Hosokawa Y, Nanishi K, Zaitsu M, Tabuchi T.
https://obgyn.onlinelibrary.wiley.com/doi/10.1111/jog.15203
J Obstet Gynaecol Res. 2022.
(2022/2/25)

Efficacy of remdesivir in hospitalized nonsevere COVID-19 patients in Japan: A large observational study using the COVID-19 Registry Japan.

Tsuzuki S, Hayakawa K, Uemura Y, Shinozaki T, Matsunaga N, Terada M, Suzuki S, Asai Y, Kitajima K, Saito S, Yamada G, Shibata T, Kondo M, Izumi K, Hojo M, Mizoue T, Yokota K, Nakamura-Uchiyama F, Saito F, Sugiura W, Ohmagari N.
https://doi.org/10.1016/j.ijid.2022.02.039
Int J Infect Dis. 2022.
(2022/2/19)

Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine.

Miyazato Y, Yamamoto K, Yamada G, Kubota S, Ishikane M, Sugiyama M, Ueno M, Matsunaga A, Miyoshi-Akiyama T, Ishizaka Y, Ohmagari N.
https://doi.org/10.3201/eid2804.212585
Emerg Infect Dis. 2022.
(2022/2/11)

Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 panel, a rapid multiplex PCR method for the diagnosis of COVID-19.

Uraki R, Imai M, Ito Ishikane M, Unoki-Kubota H, Moriya A, Kutsuna S, Ando H, Kaburagi Y, Suzuki T, Iwamoto N, Kimura M, Ohmagari N.
https://doi.org/10.1016/j.jiac.2022.02.004
J Infect Chemother. 2022.
(2022/2/9)

SARS-CoV-2 Infections in Close Contacts of Positive Cases in the Olympic and Paralympic Village at the 2021 Tokyo Olympic and Paralympic Games.

Akashi H, Shimada S, Tamura T, Chinda E, Kokudo N.
https://doi.org/10.1001/jama.2022.0818
JAMA. 2022.
(2022/2/3)

Association between eating balanced meals and depressive symptoms in Japanese hospital workers during the COVID-19 pandemic.

Miki T, Yamamoto S, Fukunaga A, Inoue Y, Ishiwari H, Ishii M, Miyo K, Konishi M, Ohmagari N, Mizoue T.
https://doi.org/10.1002/npr2.12230
Neuropsychopharmacol Rep. 2022.
(2022/2/2)

Three myths of disseminating COVID-19 information to vulnerable migrants in Japan: lessons learned during the pandemic.

Kiyohara H, Teshima Y, Hoshino HA, Kanda M, Matsuoka S, Iwamoto A, Fujita M.
https://doi.org/10.1186/s41182-022-00404-9
Trop Med Health. 2022.
(2022/2/1)

Risk factors associated with asymptomatic hypoxemia among COVID-19 patients: a retrospective study using the nationwide Japanese registry, COVIREGI-JP.

Akiyama Y, Morioka S, Asai Y, Sato L, Suzuki S, Saito S, Matsunaga N, Hayakawa K, Ohmagari N.
https://doi.org/10.1016/j.jiph.2022.01.014
J Infect Public Health. 2022.
(2022/1/31)

Cardiovascular Complications of Hospitalized Patients With Coronavirus Disease 2019 in a Japanese Registry in 2020.

Hiroi Y, Ohtsu H, Uemura Y, Hayakawa K, Asai Y, Kutsuna S, Terada M, Sugiura W, Ohmagari N.
https://doi.org/10.1253/circj.CJ-21-0687
Circ J. 2022.
(2022/1/29)

Impact of newly diagnosed diabetes on coronavirus disease 2019 severity and hyperglycemia.

Uchihara M, Bouchi R, Kodani N, Saito S, Miyazato Y, Umamoto K, Sugimoto H, Kobayashi M, Hikida S, Akiyama Y, Ihana-Sugiyama N, Ohsugi M, Tanabe A, Ueki K, Takasaki J, Hojo M, Kajio H.
https://onlinelibrary.wiley.com/doi/full/10.1111/jdi.13754
J Diabetes Investig. 2022.
(2022/1/24)

Green tea consumption and SARS-CoV-2 infection among staff of a referral hospital in Japan.

Nanri A, Yamamoto S, Konishi M, Ohmagari N, Mizoue T.
https://doi.org/10.1016/j.nutos.2022.01.002
Clin Nutr Open Sci. 2022.
(2022/1/13)

Comorbidities as Risk Factors for Severe Disease in Hospitalized Elderly COVID-19 Patients by Different Age-Groups in Japan.

Asai Y, Nomoto H, Hayakawa K, Matsunaga N, Tsuzuki S, Terada M, Ohtsu H, Kitajima K, Suzuki K, Suzuki T, Nakamura K, Morioka S, Saito S, Saito F, Ohmagari N.
https://doi.org/10.1159/000521000
Gerontology. 2022.
(2022/1/7)

Two cases of breakthrough SARS-CoV-2 infections caused by the Omicron variant (B.1.1.529 lineage) in international travelers to Japan.

Maruki T, Iwamoto N, Kanda K, Okumura N, Yamada G, Ishikane M, Ujiie M, Saito M, Fujimoto T, Kageyama T, Saito T, Saito S, Suzuki T, Ohmagari N.
https://doi.org/10.1093/cid/ciab1072
Clin Infect Dis. 2022.
(2022/1/3)

The first eleven cases of SARS-CoV-2 Omicron variant infection in Japan: a focus on viral dynamics.

Okumura N, Tsuzuki S, Saito S, Saito T, Takasago S, Hojo M, Iwamoto N, Ohmagari Norio.

https://doi.org/10.35772/ghm.2021.01124
Glob Health Med. 2021.
(2021/12/29)

COVID-19 breakthrough infection and post-vaccination neutralizing antibody among healthcare workers in a referral hospital in Tokyo: a case-control matching study.

Yamamoto S, Maeda K, Matsuda K, Tanaka A, Horii K, Okudera K, Takeuchi JS, Mizoue T, Konishi M, Ozeki M, Sugiyama H, Aoyanagi N, Mitsuya H, Sugiura W, Ohmagari N.
https://doi.org/10.1093/cid/ciab1048
Clin Infect Dis. 2021.
(2021/12/24)

Smoking and severe illness in hospitalized COVID-19 patients in Japan.

Matsushita Y, Yokoyama T, Hayakawa K, Matsunaga N, Ohtsu H, Saito S, Terada M, Suzuki S, Morioka S, Kutsuna S, Mizoue T, Hara H, Kimura A, Ohmagari N.
https://doi.org/10.1093/ije/dyab254
Int J Epidemiol. 2021.
(2021/12/11)

Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens.

Uraki R, Imai M, Ito M, Shime H, Odanaka M, Okuda M, Kawaoka Y, Yamazaki S.
https://doi.org/10.1371/journal.ppat.1010085
PLoS Pathog. 2021.
(2021/12/9)

Safety of casirivimab/imdevimab administration in a SARS-CoV-2 positive maintenance dialysis patient in Japan.

Terakawa K, Katagiri D, Shimada K, Sato L, Takano H.
https://doi.org/10.1007/s13730-021-00671-1
CEN Case Rep. 2022.
(2021/11/27)

Clinical outcomes of corticosteroids for COVID-19 patients at the National Center for Global Health and Medicine during the first wave of infections.

Morita C, Suzuki M, Izumi S, Tsukada A, Tsujimoto Y, Sakamoto K, Hashimoto M, Takasaki J, Ohmagari N, Hojo M.
https://doi.org/10.1016/j.resinv.2021.11.001
Respir Investig. 2021.
(2021/11/26)

Sensitivity of three antibody assays to SARS-CoV-2 nucleocapsid protein in relation to timing since diagnosis.

Mizoue T, Yamamoto S, Tanaka A, Oshiro Y, Inamura N, Konishi M, Ozeki M, Ohmagari N.
https://doi.org/10.35772/ghmo.2021.01030
GHM Open. 2021.
(2021/11/25)

Extracorporeal membrane oxygenation may decrease the plasma concentration of remdesivir in a patient with severe coronavirus disease 2019.

Ide S, Saito S, Akazawa T, Furuya T, Masuda J, Nagashima M, Asai Y, Ogawa T, Yamamoto R, Ishioka H, Kanda K, Okuhama A, Wakimoto Y, Suzuki T, Akiyama Y, Miyazato Y, Nakamura K, Nakamoto T, Nomoto H, Moriyama Y, Ota M, Morioka S, Matsuda W, Uemura T, Kobayashi K, Sasaki R, Katagiri D, Kutsuna S, Hayakawa K, Ohmagari N.
https://doi.org/10.1016/j.idcr.2021.e01343
IDCases. 2021.
(2021/11/16)

Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2.

Sakai-Tagawa Y, Yamayoshi S, Halfmann PJ, Kawaoka Y.
https://doi.org/10.3390/v13112183
Viruses. 2021;13(11):2183.
（2021/10/29）

Clinical characteristics and prognosis of immunosuppressed inpatients with COVID-19 in Japan.

Nomoto H, Suzuki S, Asai Y, Hayakawa K, Gatanaga H, Terada M, Suzuki K, Ohtsu H, Toyoda A, Ohmagari N.
https://doi.org/10.1016/j.jiac.2021.10.021
J Infect Chemother. 2021.
(2021/10/28)

Global landscape of the COVID-19 vaccination policy: Ensuring equitable access to quality-assured vaccines.

Wakabayashi M, Ezoe S, Yoneda M, Katsuma Y, Iso H.
https://doi.org/10.35772/ghmo.2021.01029
GHM Open. 2021.
(2021/10/21)

Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus disease.

Okuhama A, Hotta M, Ishikane M, Kawashima A, Miyazato Y, Terada M, Yamada G, Kanda K, Inada M, Sato L, Sato M, Akiyama Y, Suzuki T, Nakamoto T, Nomoto H, Ide S, Nakamura K, Saito S, Kinoshita N, Yamamoto K, Morioka S, Ujiie M, Hayakawa K, Kustuna S, Shida Y, Tajima T, Teruya K, Funato Y, Yamamoto M, Izumi S, Hojo M, Sugiyama H, Ohmagari N.
https://doi.org/10.1016/j.jiac.2021.10.013
J Infect Chemother. 2021.
(2021/10/19)

Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan.

Suzuki T, Asai Y, Ide S, Fukuda S, Tanaka A, Shimanishi Y, Takahashi K, Terada M, Sato L, Sato M, Inada M, Yamada G, Miyazato Y, Akiyama Y, Nomoto H, Nakamoto T, Nakamura K, Togano T, Morioka S, Kinoshita-Iwamoto N, Saito S, Kutsuna S, Ohmagari N.
https://doi.org/10.1016/j.jiac.2021.10.012
J Infect Chemother. 2021.
(2021/10/19)

Global effort to ensure equitable distribution of COVID-19 vaccines.

Wakabayashi M, Ezoe S, Yoneda M, Iso H.
https://doi.org/10.11477/mf.1401209716
The Journal of Public Health Practice. 2021; 85(10):697-701.
(2021/10/15)

Facilitating the deployment of Japanese human resources for responding global outbreaks of emerging and Re-emerging infectious diseases: A cross-sectional study.

Nomoto H, Ishikane M, Lee S, Komiya N, Maeki T, Matsui T, Morita K, Oshitani H, Saijo M, Yamagishi T, Yamamoto T, Ohmagari N. https://doi.org/10.1016/j.jiac.2021.09.015
J Infect Chemother. 2021.
(2021/10/8)

Interleukin-6 is upregulated and may be associated with myocardial injury in some patients who have recovered from COVID-19.

Hayama H, Ide S, Kitami Y, Hara H, Kutsuna S, Hiroi Y.

https://doi.org/10.35772/ghm.2021.01090
Glob Health Med. 2021.
(2021/10/7)

Correlation between asymptomatic cases and the incidence of COVID-19 in Japan.>

Kimura M, Uemura Y, Omagari N, Ikeda M, Sugiura W.
Epidem Pub Hel Res.2021; 1(2):1-3
https://geneft.com/article/correlation-between-asymptomatic-cases-and-the-incidence-of-covid-19-in-japan
(2021/10/4)

Angiotensin–Converting Enzyme (ACE) 1 Gene Polymorphism and Phenotypic Expression of COVID‐19 Symptoms.

Yamamoto N, Nishida N, Yamamoto R, Gojobori T, Shimotohno K, Mizokami M, Ariumi Y.
https://doi.org/10.3390/genes12101572
Genes 2021 Vol. 12 Issue 10
（2021/10/1）

Negative Results of Nucleic Acid Amplification Test for SARS-CoV-2 in Clinical Practice May Vary among Six Molecular Assays in COVID-19 Patients.

Motohashi A, Yamamoto K, Mezaki K, Moriya A, Kurokawa M, Oki H, Ando H, Isaka E, Usami A, Ide S, Nakamura K, Nakamoto T, Nomoto H, Ohmagari N.
https://doi.org/10.7883/yoken.JJID.2021.416
Jpn J Infect Dis. 2021.
(2021/9/30)

Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcgRIIA and FcgRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages

Maemura T, Kuroda M, Armbrust T, Yamayoshi S, Halfmann PJ, Kawaoka Y.
https://doi.org/10.1128/mBio.01987-21
mBio. 2021;12(5):e0198721.
（2021/9/28）

A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient.

Maruki T, Ishikane M, Suzuki T, Ujiie M, Katano H, Ohmagari N.
https://doi.org/10.1016/j.ijid.2021.09.055
Int J Infect Dis. 2021;S1201-9712(21)00767-0.
(2021/9/26)

COVID-19 and the Angiotensin-Converting Enzyme 1 D/I Genotype: Protection of People at High-Risk by Predicting the Severity of the Disease.

Yamamoto N. 
Diagn Pathol Open 5:173.
(2020/9/14)

Evaluation of SARS-CoV-2 Antibodies and the Impact of COVID-19 on the HIV Care Continuum, Economic Security, Risky Health Behaviors, and Mental Health Among HIV-Infected Individuals in Vietnam

Matsumoto S, Nagai M, Luong DAD, Nguyen HDT, Nguyen DT, Van Dinh T, Van Tran G, Tanuma J, Pham TN, Oka S.
https://doi.org/10.1007/s10461-021-03464-w
AIDS Behav. 2021.
2021/9/7

Cardiovascular implications of the COVID-19 pandemic.

Tomidokoro D, Hiroi Y.
https://doi.org/10.1016/j.jjcc.2021.09.010
Journal of Cardiology. 2021.
(2021/9/6)

Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan.

Hara H, Uemura Y, Hayakawa K, Togano T, Asai Y, Matsunaga N, Terada M, Ohtsu H, Kitajima K, Shimizu Y, Sato L, Ishikane M, Kinoshita-Iwamoto N, Shibata T, Kondo M, Izumi K, Sugiura W, Ohmagari N.
https://doi.org/10.1016/j.ijid.2021.09.014
Int J Infect Dis. 2021;S1201-9712(21)00725-6.
(2021/9/6)

Clinical Characteristics of Hospitalized COVID-19 in Children: Report From the COVID-19 Registry in Japan.

Shoji K, Akiyama T, Tsuzuki S, Matsunaga N, Asai Y, Suzuki S, Iwamoto N, Funaki T, Ohmagari N.
https://doi.org/10.1093/jpids/piab085
J Pediatric Infect Dis Soc. 2021.
(2021/9/6)

Is there an association between ABO blood types and depressive symptoms among Japanese healthcare workers during the COVID-19 pandemic?

Hoang DV, Yamamoto S, Miki T, Fukunaga A, Islam Z, Konishi M, Mizoue T.
https://doi.org/10.1371/journal.pone.0256441
PLoS One. 2021;16(8):e0256441.
(2021/8/27)

Strong alkaline electrolyzed water efficiently inactivates SARS-CoV-2, other viruses, and Gram-negative bacteria.

Suzuki Y, Hishiki T, Emi A, Sakaguchi S, Itamura R, Yamamoto R, Matsuzawa T, Shimotohno K, Mizokami M, Nakano T, Yamamoto N. 
https://doi.org/10.1016/j.bbrc.2021.08.048
Biochem Biophys Res Commun. 2021; 575:36-41.
(2021/8/23)

Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: The potential contribution to alleviating isolation of COVID-19 patients.

Nomoto H, Yamamoto K, Yamada G, Suzuki M, Kinoshita N, Takasaki J, Moriya A, Maeda K, Kimura M, Ohmagari N.
https://doi.org/10.1016/j.jiac.2021.08.015
J Infect Chemother. 2021;27(11):1669-1673.
(2021/8/14)

Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan.

Ujiie M, Tsuzuki S, Nakamoto T, Iwamoto N.
https://wwwnc.cdc.gov/eid/article/27/11/21-1565_article
Emerg Infect Dis. 2021;27(11).
(2021/8/13)

A single-center descriptive study of untraced sources of infection among new cases of coronavirus disease in Tokyo, Japan.

Hikida S, Morioka S, Fujii N, Tajima T, Terayama Y, Sugiura Y, Ishikane M, Takasaki J, Hojo M, Ohmagari N.
https://doi.org/10.35772/ghm.2021.01092
Glob Health Med. 2021.
(2021/8/9)

Predicting respiratory failure for COVID-19 patients in Japan: A simple clinical score for evaluating the need for hospitalization.

Yamada G, Hayakawa K, Matsunaga N, Terada M, Suzuki S, Asai Y, Ohtsu H, Toyoda A, Kitajima K, Tsuzuki S, Saito S, Ohmagari N.
https://doi.org/10.1017/S0950268821001837
Epidemiol Infect. 2021.
(2021/7/30)

Epidemiology and risk of COVID-19 among travelers at airport and port quarantine stations across Japan: a nationwide descriptive analysis and an individually matched case-control study.

Tsuboi M, Hachiya M, Ohtsu H, Akashi H, Miyoshi C, Umeda T.
https://doi.org/10.1093/cid/ciab659
Clin Infect Dis. 2021;ciab659.
(2021/7/28)

Confronting COVID-19： Current Issues of SARS-CoV-2 Therapeutic Drug/Vaccine Development.

Sugiura W.
https://doi.org/10.3820/jjpe.26.91
薬剤疫学. 2021;26(1):91-97.
(2021/7/26)

The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan.

Togano T, Uemura Y, Asai Y, Hayakawa K, Matsunaga N, Terada M, Ohtsu H, Suzuki S, Toyoda A, Hara H, Sato R, Ishikane M, Kinoshita-Iwamoto N, Hangaishi A, Ohmagari N.
https://doi.org/10.1016/j.jiac.2021.07.016
J Infect Chemother. 2021.
(2021/7/24)

Infectious disease activity during the COVID-19 epidemic in Japan: Lessons learned from prevention and control measures.

Sawakami T, Karako K, Song P, Sugiura W, Kokudo N.
https://doi.org/10.5582/bst.2021.01269
Biosci Trends. 2021.
(2021/7/13)

Clinical and radiological findings of silent hypoxia among COVID-19 patients.

Okuhama A, Ishikane M, Hotta M, Sato L, Akiyama Y, Morioka S, Suzuki S, Tajima T, Yamamoto M, Teruya K, Izumi S, Ohmagari N.
https://doi.org/10.1016/j.jiac.2021.07.002
J Infect Chemother. 2021;S1341-321X(21)00185-9.
(2021/7/13)

COVID-19 and liver surgery in France, Italy, Japan, and the United States: A report of a single topic conference of Eastern and Western Association for Liver Tumors (EWALT) 2021.

Ito K, Takemura N, Hasegawa K, Kokudo N.

https://doi.org/10.35772/ghm.2021.01062
Glob Health Med. 2021.
(2021/7/5)

Traditional Chinese medicine for treatment of novel infectious diseases: Current status and dilemma.

Qi F, Tang W.
https://doi.org/10.5582/bst.2021.01263
Biosci Trends. 2021.
(2021/7/1)

Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review.

Minamimoto R, Kiyomatsu T.
https://doi.org/10.35772/ghm.2021.01076
Glob Health Med. 2021; 3(3): 129-133.
(2021/6/27)

Behavioral changes adopted to constrain COVID-19 in Japan: What are the implications for seasonal influenza prevention and control?

Sawakami T, Karako K, Song P.
https://doi.org/10.35772/ghm.2021.01066
Glob Health Med. 2021; 3(3): 125-128.
(2021/6/25)

Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan.

Terada M, Ohtsu H, Saito S, Hayakawa K, Tsuzuki S, Asai Y, Matsunaga N, Kutsuna S, Sugiura W, Ohmagari N.
Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan.
https://doi.org/10.1136/bmjopen-2020-047007
BMJ Open. 2021;11(6):e047007.
(2021/6/15)

How we secured a COVID-19 convalescent plasma procurement scheme in Japan.

Terada M, Kutsuna S, Togano T, Saito S, Kinoshita N, Shimanishi Y, Suzuki T, Miyazato Y, Inada M, Nakamoto T, Nomoto H, Ide S, Sato M, Maeda K, Matsunaga A, Satake M, Matsubayashi K, Tsuno H, Kojima M, Kuramistu M, Tezuka K, Ikebe E, Okuma K, HamTerada Maguchi I, Shiratori K, Sato M, Kawakami Y, Inaba K, Igarashi S, Yamauchi R, Matsumura M, Ishimaru K, Zhang B, Kuge C, Ishihara M, Gouda M, Tanaka K, Ishizaka Y, Ohmagari N.
https://doi.org/10.1111/trf.16541
Transfusion. 2021;61(7):1998-2007.
(2021/6/7)

A pilot study of viral load in stools of patients with COVID-19 and diarrhea.

Akiyama Y, Kinoshita N, Sadamasu K, Nagashima M, Yoshida I, Kusaba Y, Suzuki T, Nagashima M, Ishikane M, Takasaki J, Yoshimura K, Ohmagari N.
https://doi.org/10.788/yoken.JJID.2021.018
Jpn J Infect Dis. 2021.
（2021/5/31）

A Kidney Transplant Patient Who Died of COVID-19-associated Severe Acute Respiratory Distress Syndrome: A Case Report.

Tsukada A, Suzuki M, Kishino Y, Misumi K, Igari T, Nakajima N, Sato Y, Suzuki T, Katsuno T, Kusaba Y, Tsujimoto Y, Sakamoto K, Hashimoto M, Terada J, Takasaki J, Izumi S, Hojo M, Sugiyama H.
https://doi.org/10.2169/internalmedicine.7089-21
Intern Med. 2021.
（2021/5/29）

Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan.

Yamamoto S, Tanaka A, Oshiro Y, Ishii M, Ishiwari H, Konishi M, Matsuda K, Ozeki M, Miyo K, Maeda K, Mizoue T, Sugiura W, Mitsuya H, Sugiyama H, Ohmagari N.
https://doi.org/10.1016/j.jinf.2021.05.017
J Infect. 2021;83(2):237-279.
(2021/5/25)

Evaluation of High-Sensitivity Cardiac Troponin T Levels in Japanese Patients Recently Recovered From Coronavirus Disease 2019.

Ide S, Hayama H, Asai Y, Terada M, Nomoto H, Kutsuna S, Ohmagari N, Hiroi Y.
https://doi.org/10.1253/circj.CJ-21-0219
Circ J. 2021;85(6):944-947.
（2021/5/15）

Does the SARS-CoV-2 rapid antigen test result correlate with the viral culture result?

Yamamoto K, Nagashima M, Yoshida I, Sadamasu K, Kurokawa M, Nagashima M, Kinoshita N, Maeda K, Takasaki J, Teruya K, Ohmagari N.
https://doi.org/10.1016/j.jiac.2021.05.006
J Infect Chemother. 2021;27(8):1273-1275.
（2021/5/12）

Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities and Explain the Huge Mortality Disparity between the East and the West?

Yamamoto N, Yamamoto R, Ariumi Y, Mizokami M, Shimotohno K, Yoshikura H.
https://doi.org/10.3390/ijms22095000
Int J Mol Sci. 2021;22(9):5000.
(2021/5/8)

Clinical course of alopecia after severe acute respiratory syndrome coronavirus 2 infection

Suzuki T, Kutsuna S, Saito S, Kawashima A, Okuhama A, Kanda K, Sato L, Inada M, Akiyama Y, Ide S, Nakamura K, Nakamoto T, Yamamoto K, Ishikane M, Kinoshita N, Morioka S, Hayakawa K, Ohmagari N.
https://doi.org/10.1016/j.ijid.2021.04.088
Int J Infect Dis. 2021;107:255-256.
（2021/5/4）

Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies.

Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Tsuchiya K, Miura K, Sairenji Y, Kinoshita N, Ujiie M, Kutsuna S, Ishizaka Y, Mitsuya H, Ohmagari N.
J Infect Chemother. 2021.
https://www.jiac-j.com/article/S1341-321X(21)00124-0/pdf
(2021/4/24)

Clinical Manifestations of Coronavirus Disease 2019.

Kutsuna S.
JMA J. 2021;4(2):76-80.
https://doi.org/doi: 10.31662/jmaj.2021-0013
(2021/4/15)

External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan.

Yamada G, Hayakawa K, Asai Y, Matsunaga N, Ohtsu H, Hojo M, Hashimoto M, Kobayashi K, Sasaki R, Okamoto T, Yanagawa Y, Katagiri D, Terada M, Suzuki M, Sato L, Miyazato Y, Ishikane M, Morioka S, Saito S, Ohmagari N.
J Infect Chemother. 2021.
https://doi.org/10.1016/j.jiac.2021.04.008　
（2021/4/12）

Hospital capacity during the COVID-19 pandemic.

Kokudo N, Sugiyama H.
Glob Health Med. 2021.
https://doi.org/10.35772/ghm.2021.01031
(2021/4/11)

Association Between Adherence to Healthy Lifestyles and Depressive Symptoms Among Japanese Hospital Workers During the COVID-19 Pandemic.

Fukunaga A, Inoue Y, Yamamoto S, Miki T, Nanri A, Ishiwari H, Ishii M, Miyo K, Konishi M, Ohmagari N, Mizoue T.
 Asia Pac J Public Health. 2021.
https://doi.org/10.1177%2F10105395211007604
 (2021/4/8)

Microbiological Testing for Coronavirus Disease 2019.

Yamamoto K, and Ohmagari N. 
 JMA Journal. 2021.
https://www.jmaj.jp/detail.php?id=10.31662%2Fjmaj.2021-0012
 (2021/4/2)

Consistency of the results of rapid serological tests for SARS-CoV-2 among healthcare workers in a large national hospital in Tokyo, Japan.

Yamamoto S, Tanaka A, Kobayashi S, Oshiro Y, Ozeki M, Maeda K, Matsuda K, Miyo K, Mizoue T, Sugiura W, Mitsuya H, Sugiyama H, Ohmagari N.
 Glob Health Med. 2021.
https://doi.org/10.35772/ghm.2021.01022
  (2021/4/2)

Elevated high-sensitivity troponin is associated with subclinical cardiac dysfunction in patients recovered from coronavirus disease 2019.

Hayama H,Ide Satoshi, Moroi M, Kitami Y, Bekki N, Kubota S, Uemura Y, Hara H, Kutsuna S, Ohmagari N, Hiroi Y.
Glob Health Med. 2021.
https://doi.org/10.35772/ghm.2021.01025
 (2021/4/2)

Association between engagement in COVID-19-related work and depressive symptoms among hospital workers in a designated COVID-19 hospital in Japan: a cross-sectional study.

Inoue Y, Yamamoto S, Fukunaga A, Hoang DV, Miki T, Islam Z, Miyo K, Ishii M, Ishiwari H, Konishi M, Ohmagari N, Mizoue T.
 BMJ Open. 2021.
https://doi.org/10.1136/bmjopen-2021-049996
 (2021/4/1)

Acute portal vein thrombosis with COVID-19 and cirrhosis.

Miyazato Y, Ishikane M, Inada M, Ohmagari N.
Asia Pac J Public Health. 2021.
https://doi.org/10.1016/j.idcr.2021.e01094
(2021/3/27)

Clinical experience with high-flow nasal cannulas for coronavirus disease 2019 patients in Japan.

Katsuno T, Suzuki M, Hojo M, Terada J, Nakamura K, Suzuki T, Miyazato Y, Sugiyama H.
 Respir Invest. 2021.
https://doi.org/10.1016/j.resinv.2021.02.011
 (2021/3/26)

Diagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using RT-PCR.

Tsujimoto Y, Terada J, Kimura M, Moriya A, Motohashi A, Izumi S, Kawajiri K, Hakkaku K, Morishita M, Saito S, Takumida H, Watanabe H, Tsukada A, Morita C, Yamaguchi Y, Katsuno T, Kusaba Y, Sakamoto K, Hashimoto M, Suzuki M, Takasaki J, Hojo M, Miyoshi-Akiyama T, Sugiyama H.
 Infect Dis (Lond). 2021.
https://doi.org/10.1080/23744235.2021.1903550
 (2021/3/24)

Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma.

Maeda K, Higashi-Kuwata N, Kinoshita N, Kutsuna S, Tsuchiya K, Hattori SI, Kouki Matsuda , Takamatsu Y, Gatanaga H, Oka S, Sugiyama H, Ohmagari N, and Mitsuya H. 
 Sci Rep. 2021;11(1):5563.
https://doi.org/10.1038/s41598-021-84733-5
 (2021/3/10)

Effective screening strategies for detection of asymptomatic COVID-19 travelers at airport quarantine stations: Exploratory findings in Japan.

Norizuki M, Hachiya M, Motohashi A, Moriya A, Mezaki K, Kimura M, Sugiura W, Akashi H, Umeda T.
 Glob Health Med. 2021.
https://doi.org/10.35772/ghm.2020.01109
(2021/3/9)

COVID-19 and bronchial asthma: current perspectives.

Hojo M, Terada-Hirashima J, Sugiyama H.
 Glob Health Med. 2021.
https://doi.org/10.35772/ghm.2020.01117
(2021/3/9)

Care for children's mental health during the COVID-19 pandemic in Japan

Usami M, Sasaki S, Sunakawa H, Toguchi Y, Tanese S, Saito K, Shinohara R, Kurokochi T, Sugimoto K, Itagaki K, Yoshida Y, Namekata S, Takahashi M, Harada I, Hakoshima Y, Inazaki K, Yoshimura Y, Mizumoto Y.
Glob Health Med. 2021.
https://doi.org/10.35772/ghm.2020.01081
(2021/3/6)

Positive ratio of polymerase chain reaction (PCR) and validity of pre-screening criteria at an outpatient screening center during the early phase of the COVID-19 epidemic in Japan.

Ide S, Hayakawa K, Yamamoto K, Tsuzuki S, Tanuma J, Ohara K, Yamada G, Okuhama A, Kanda K, Suzuki T, Akiyama Y, Miyazato Y, Nakamura K, Nomoto H, Nakamoto T, Ujiie M, Saito S, Morioka S, Ishikane M, Kinoshita N, Kutsuna S, Tanaka K, Ohmagari N.
Jpn J Infect Dis.
https://doi.org/10.7883/yoken.JJID.2020.813
(2021/2/26)

Enhancing the use of computed tomography and cardiac catheterizationangiography in Zambia: A project report on a global extension ofmedical technology in Japan.

Kono Y, Shimizu E, Matsunaga F, Egami Y, Yoneda K, Sakamoto K, Mubita M, Sichizya V S , Wakamatsu K, Terashima M, Fujita N.
 Glob Health Med. 2020.
https://doi.org/10.35772/ghm.2020.01107
（2020/2/18）

The effect of the COVID-19 pandemic on incidence and characteristics of pulmonary embolism.

Tomidokoro D, Hayama H, Okazaki T, Hara H, Hiroi Y. 
J-STAGE. 2021.
https://doi.org/10.35772/ghm.2020.01119 
（2021/2/15）

Japanese WHO Collaborating Centres (WHO CCs) fight against COVID-19.

Fujita M, Umeda T, Fujita N, Nishioka T, Iwamoto A, Ohmagari N, Ishikane M, Akashi H, Kokudo Norihiro.
J-STAGE. 2021.
https://doi.org/10.35772/ghm.2020.01093
（2021/2/11）

Investigator initiated clinical trial of remdesivir for the treatment of COVID-19 in Japan.

Saito S, Hayakawa K, Mikami A, Izumi S, Funazaki H, Ashida S, Sugiura W, Sugiyama H, Kokudo N, Ohmagari N. 
J-STAGE. 2021.
https://doi.org/10.35772/ghm.2020.01106
（2021/2/11）

Transmission dynamics of SARS-CoV-2 on the Diamond Princess uncovered using viral genome sequence analysis.

Hoshino K, Maeshiro T, Nishida N, Sugiyama M, Fujita J, Gojobori T, Mizokami M.
Gene 2021.
https://doi.org/10.1016/j.gene.2021.145496
（2021/2/3）

Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.

Tanaka A, Yamamoto S, Miyo K, Mizoue T, Maeda K, Sugiura W, Mitsuya H, Sugiyama H, Ohmagari N. Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan. 
 J Infect. 2021.
https://doi.org/10.1016/j.jinf.2021.01.010
（2021/1/29）

Overview of the characteristics of and responses to the three waves of COVID-19 in Japan during 2020-2021.

Karako K, Song P, Chen Y, Tang W, Kokudo N.
 Biosci Trends. 2021.
https://doi.org/10.5582/bst.2021.01019
（2021/1/29）

A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication.

Hattori SI, Higashi-Kuwata N, Hayashi H, Allu SR, Raghavaiah J, Bulut H, Das D, Anson BJ, Lendy EK, Takamatsu Y, Takamune N, Kishimoto N, Murayama K, Hasegawa K, Li M, Davis DA, Kodama EN, Yarchoan R, Wlodawer A, Misumi S, Mesecar AD, Ghosh AK, Mitsuya H.
 Nat Commun. 2021
https://doi.org/10.1038/s41467-021-20900-6
（2021/1/28）

Association between living with others and depressive symptoms in Japanese hospital workers during the COVID‐19 pandemic.

Miki T, Yamamoto S, Inoue Y, Fukunaga A, Islam Z, Ishiwari H, Ishii M, Miyo K, Konishi M, Ohmagari N, Mizoue T. 
 Psychiatry Clin Neurosci. 2021.
https://doi.org/10.1111/pcn.13206
（2021/1/28）

Change of use in community services among disabled older adults during COVID-19 in Japan.

Ito T, Hirata-Mogi S, Watanabe T, Sugiyama T, Jin X, Kobayashi S, Tamiya N. Change of Use in Community Services among Disabled Older Adults during COVID-19 in Japan. 
 Int J Environ Res Public Health. 2021.
https://doi.org/10.3390/ijerph18031148  
（2021/1/28）

SARS-CoV-2 Leakage from the Gas Outlet Port during Extracorporeal Membrane Oxygenation for COVID-19.

Ogawa T, Uemura T, Matsuda W, Sato M, Ishizuka K, Fukaya T, Kinoshita N, Nakamoto T, Ohmagari N, Katano H, Suzuki T, Hosaka S.
 ASAIO J. 2021.
https://doi.org/10.1097/mat.0000000000001402
（2021/1/21）

Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19.

Kutsuna S, Asai Y, Matsunaga A, Kinoshita N, Terada M, Miyazato Y, Nakamoto T, Suzuki T, Saito S, Endo M, Kanda K, Kenji M, Takasaki J, Hojo M, Ishizaka Y, Ohmagari N. 
 J Infect Chemother. 2021.
https://doi.org/10.1016/j.jiac.2021.01.006 
（2021/1/18）

Hemoptysis and a Newly Formed Lung Bulla in a Case of Convalescent COVID-19 Pneumonia.

Sato L, Kinoshita N, Nakamoto T, Ohmagari N.
 Intern Med. 2021.
https://doi.org/10.2169/internalmedicine.5684-20
（2021/1/15）

Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission.

Yamamoto K, Suzuki M, Yamada G, Sudo T, Nomoto H, Kinoshita N, Nakamura K, Tsujimoto Y, Kusaba Y, Morita C, Moriya A, Maeda K, Yagi S, Kimura M, Ohmagari N.
 International Journal of Infectious Diseases 2020.
https://doi.org/10.1016/j.ijid.2020.12.079
（2020/12/26）

Effect of evacuation of Japanese residents from Wuhan, China, on preventing transmission of novel coronavirus infection: A modelling study.

Asai Y, Tsuzuki S, Kutsuna S, Hayakawa K, Ohmagari N.
 J Infect Chemother. 2020.
https://doi.org/10.1016/j.jiac.2020.12.011
（2020/12/16）

Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19.

Katagiri D, Ishikane M, Asai Y, Izumi S, Takasaki J, Katsuoka H, Kondo I, Ide S, Nakamura K, Nakamoto T, Nomoto H, Akiyama Y, Miyazato Y, Suzuki T, Kinoshita N, Ogawa T, Togano T, Suzuki M, Hashimoto M, Sakamoto K, Kusaba Y, Katsuno T, Fukaya T, Hojo M, Sugiyama M, Mizokami M, Okamoto T, Kimura A, Noiri E, Ohmagari N, Hinoshita F, Sugiyama H.
 J Clin Apher. 2020.
https://doi.org/10.1002/jca.21861
（2020/12/15）

Using flowchart for ophthalmic consultations in hospitalized patients with COVID-19.

Yashiro S, Ueta T, Kutsuna S, Okamoto T, Nagahara M, Ohmagari N.
 Glob Health Med. 2020.
https://doi.org/10.35772/ghm.2020.01091
（2020/12/14）

“Staying at home” to tackle COVID-19 pandemic: Rhetoric or Reality? Cross-cutting analysis of nine population groups vulnerable to homelessness in Japan.

Fujita M, Matsuoka S, Kiyohara H, Kumakura Y, Takeda Y, Goishi N, Tarui M, Inaba M, Nagai M, Hachiya M, Fujita N.
 Trop Med Health. 2020; 48(1):92.
https://doi.org/10.1186/s41182-020-00281-0
（2020/11/23）

The RACCO Trial to Assess the Efficacy and Safety of Inhaled Ciclesonide for Asymptomatic and Mild Patients with Covid-19: A Study Protocol for a Multi-center, Open-labeled, Randomized Controlled Trial.

Terada-Hirashima J, Suzuki M, Uemura Y, Hojo M, Mikami A, Sugiura W, Ohmagari N, Sugiyama H.
 JMIR Res Protoc. 2020.
https://doi.org/10.2196/23830
（2020/11/18）

Telephone consults at the Infectious Disease Outpatient Clinic during the early period of the COVID-19 epidemic.

Osanai Y, Kinoshita N, Hayakawa K, Tanaka K, Hamano T, Kutsuna S, Ujiie M, Morioka S, Yamamoto K, Isikane M, Saito Sho, Sugiura Y, Ohmagari.
 Glob Health Med. 2020.
https://doi.org/10.35772/ghm.2020.01085
（2020/11/16）

A case of dialysis interruption caused by voluntary quarantine against the coronavirus disease (COVID-19) after returning from overseas to Japan.

Arai Y, Katagiri D, Hinoshita F. 
 Ther Apher Dial. 2020.
https://doi.org/10.1111/1744-9987.13608
（2020/11/15）

Validation of a new SARS-CoV-2 gene detection POCT reagent Smart Gene COVID-19 detection kit with nasopharyngeal swab.

Moriya A, Yamamoto K, Akiyama T, Kinoshita N, Sudo T, Motohashi A, Usami A, Isaka E, Ando H, Ohki H, Kurokawa M, Mezaki K, Tanaka A, Shoji M, Ozeki M, Kimura M, Ohmagari N.
  J Japan Clin Microbiol. 2021;31(2):103-107.
http://journal.kyorin.co.jp/journal/jscm/detail_j.php?-DB=jscm&-recid=1152&-action=browse
(2020/11/15)

A Review of Four Cases of COVID-19 with a Repeat-positive PCR Test for SARS-CoV-2 after Hospital Discharge.

Ujiie M, Kato Y, Kuroki J, Terashima T, Ito T, Asaoka T, Shirano M, Kakinoki Y.
  J-STAGE. 2020.
http://journal.kansensho.or.jp/Disp?style=abst&vol=95&mag=0&number=1&start=32
（2020/11/9）

Association of plain computed tomography-determined pulmonary artery-to-aorta ratio with clinical severity of coronavirus disease 2019.

Hayama H, Ishikane M, Sato R, Kanda K, Kinoshita N, Izumi S, Ohmagari N, Hiroi Y.  
 Pulmonary Circulation. November 2020.
https://doi.org/10.1177/2045894020969492
（2020/11/5）

Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-Center, Observational Study in Tokyo, Japan.

Akiyama Y, Morioka S, Wakimoto Y, Kawashima A, Kanda K, Okuhama A, Suzuki T, Miyazato Y, Nomoto H, Ide S, Nakamoto T, Nakamura K, Ota M, Moriyama Y, Takaya S, Yamada K, Taguchi M, Sugito E, Izuka S, Ishiguro K, Kobayashi T, Miyake W, Kubota S, Ishikane M, Kinoshita N, Yamamoto K, Ujiie M, Kutsuna S, Hayakawa K, Saito S, Ohmagari N.
 Intern Med. 2020.
https://doi.org/10.2169/internalmedicine.5614-20
（2020/11/2)

First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics.

Saito S, Asai Y, Matsunaga N, Hayakawa K, Terada M, Ohtsu H, Tsuzuki S, Ohmagari N.
 J Infect. 2020
https://doi.org/10.1016/j.jinf.2020.10.033
（2020/11/2）

Beau’s lines and leukonychia in a patient with coronavirus disease.

Ide S, Morioka S, Inada M, Ohmagari N.
 Intern Med Advance Publication. 2020.
https://doi.org/10.2169/internalmedicine.6112-20
（2020/11/2）

Prolonged and late-onset symptoms of coronavirus disease 2019.

Miyazato Y, Morioka S, Tsuzuki S, Akashi M, Osanai Y, Tanaka K, Terada M, Suzuki M, Kutsuna S, Saito S,  Hayakawa K, Ohmagari N.
 Open Forum Infectious Diseases. 2020.
https://doi.org/10.1093/ofid/ofaa507
（2020/10/21）

Periungual desquamation in a Japanese Adult recovering from severe COVID-19.

Nakamoto T, Ishikane M, Sasaki R, Ohmagari N.
 Int J Infect Dis. 2020.
https://doi.org/10.1016/j.ijid.2020.10.029
（2020/10/17）

Environmental surface and air contamination in severeacute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severity.

Nakamura K, Morioka S, Kutsuna S, Iida S, Suzuki T, Kinoshita N, Suzuki T, Sugiki Y, Okuhama A, Kanda K, Wakimoto Y, Ujiie M, Yamamoto K, Ishikane M, Moriyama Y, Ota M, Nakamoto T, Ide S, Nomoto H, Akiyama Y, Miyazato Y, Hayakawa K, Saito S, Ohmagari N. 
 Infection Prevention in Practice. 2020;2(4):100098.
https://doi.org/10.1016/j.infpip.2020.100098
（2020/10/13）

Nightlife clusters of coronavirus disease in Tokyo between March and April 2020.

Takaya S, Tsuzuki S, Hayakawa K, Kawashima A, Okuhama A, Kanda K, Suzuki T, Akiyama Y, Miyazato Y, Ide S, Nakamura K, Nomoto H, Nakamoto T, Hikida S, Tanuma J, Ohara K, Ito T, Baba T, Yamamoto K, Ujiie M, Saito S, Morioka S, Ishikane M, Kinoshita N, Kutsuna S, Ohmagari N. 
 Epidemiol Infect. 2020;148:e250.
https://doi.org/10.1017/S0950268820002496
（2020/10/13）

Depressive symptoms in students during school closure due to COVID-19 in Shanghai.

Xiang M, Yamamoto S, Mizoue T.
 Psychiatry Clin Neurosci. 2020.
https://doi.org/10.1111/pcn.13161
（2020/9/30）

Clinical epidemiology of hospitalized patients with COVID-19 in Japan: Report of the COVID-19 REGISTRY JAPAN.

Matsunaga N, Hayakawa K, Terada M, Ohtsu H, Asai Y, Tsuzuki S, Suzuki S, Toyoda A, Suzuki K, Endo M, Fujii N, Suzuki M, Saito Sho, Uemura Y, Shibata T, Kondo M, Izumi K, Terada-Hirashima J, Mikami A, Sugiura W, Ohmagari N. 
 Clinical Infectious Diseases. 2020. ciaa1470.
https://doi.org/10.1093/cid/ciaa1470
（2020/9/28）

Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.

Kutsuna S, Asai Y, Matsunaga A. 
 N Engl J Med. 2020;383(17):1695-1696. 
https://doi.org/10.1056/NEJMc2027051
（2020/9/23）

Strengthening public health response after COVID-19: Review of the Centers for Disease Control and Prevention of the United States to envision "Japan CDC".

Sugiyama T, Imai K, Higashi T, Tomio J, Tamiya N.
 Japanese Journal of Public Health. 2020;67(9):567-572. Japanese.
https://doi.org/10.11236/jph.20-069
（2020/9/15）

Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19.

Sugiyama M, Kinoshita N, Ide S, Nomoto H, Nakamoto T, Saito S, Ishikane M, Kutsuna S, Hayakawa K, Hashimoto M, Suzuki M, Izumi S, Hojo M, Tsuchiya K, Gatanaga H, Takasaki J, Usami M, Kano T, Yanai H, Nishida N, Kanto T, Sugiyama H, Ohmagari N, Mizokami M.
 Gene. 2020;766:145145.
https://doi.org/10.1016/j.gene.2020.145145
（2020/9/15）

Global health landscape challenges triggered by COVID-19.

Nakatani H, Katsuno K, Urabe H.
 Inflamm Regen. 2020;40:34.
https://doi.org/10.1186/s41232-020-00144-5
（2020/9/14）

Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers.

Suzuki T, Hayakawa K, Ainai A, Iwata-Yoshikawa N, Sano K, Nagata N, Suzuki T, Wakimoto Y, Akiyama Y, Miyazato Y, Nakamura K, Ide S, Nomoto H, Nakamoto T, Ota M, Moriyama Y, Sugiki Y, Saito S, Morioka S, Ishikane M , Kinoshita N, Kutsuna S, Ohmagari N.
 J Infect Chemother. 2020.
https://doi.org/10.1016/j.jiac.2020.09.006
（2020/9/9）

Successful Recovery from COVID-19-associated Acute Respiratory Failure with Polymyxin B-immobilized Fiber Column-direct Hemoperfusion.

Kusaba Y, Izumi S , Takasaki J, Suzuki M, Katagiri D, Katsuno T, Matsumoto S, Sakamoto K, Hashimoto M,  Ohmagari N, Katano H, Suzuki T, Hojo M, Sugiyama H.
 Internal Medicine. 2020;59(19):2405-2408.
https://doi.org/10.2169/internalmedicine.5413-20
（2020/8/29）

Shifting workstyle to teleworking as a new normal in face of COVID-19: analysis with the model introducing intercity movement and behavioral pattern.

Karako K, Song P, Chen Y, Tang W.
 Ann Transl Med. 2020;8(17):1056.
http://dx.doi.org/10.21037/atm-20-5334
（2020/8/24）

GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection.

Hattori S-i, Higshi-Kuwata N, Raghavaiah J, Das D, Bulut H, Davis D, Takamatsu Y, Matsuda K, Takamune N, Kishimoto N, Okamura T, Misumi S, Yarchoan R, Maeda K, Ghosh A, Mitsuya H.
 mBio. 2020;11:e01833-20.
https://doi.org/10.1128/mBio.01833-20
（2020/8/20）

Case of adult large vessel vasculitis after SARSCoV-2 infection.

Oda R, Inagaki T, Ishikane M, Hotta M, Shimomura A, Sato M, Nakamoto T, Akiyama Y, Yamamoto K,  Minamimoto R, Kaneko H, Ohmagari N.
 Ann Rheum Dis. 2020.
http://dx.doi.org/10.1136/annrheumdis-2020-218440
（2020/8/11）

Do the Asia and Oceania Federation of Obstetrics and Gynecology members' websites provide information targeting women in the context of the COVID‐19 pandemic?

Kikuchi S, Komagata T, Obara H.
 Journal of Obstetrics and Gynecology. 2020.
https://doi.org/10.1111/jog.14377
（2020/8/7）

Computed tomography surveillance helps tracking COVID-19 outbreak.

Machitori A, Noguchi T, Kawata Y, Horioka N, Nishie A, Kakihara D, Ishigami K, Aoki S, Imai Y.
 Jpn J Radiol. 2020.
https://doi.org/10.1007/s11604-020-01026-z
（2020/8/7）

When should clinicians repeat SARS-CoV-2 RT-PCR?: Repeat PCR testing targeting patients with pulmonary CT findings suggestive of COVID-19.

Yamamoto K, Saito S, Hayakawa K, Hashimoto M, Takasaki J, Ohmagari N.
 Jpn J Infect Dis. 2020.
https://doi.org/10.7883/yoken.JJID.2020.531
（2020/8/3）

Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers.

Katagiri D, Ishikane M, Asai Y, Kinoshita N, Ota M, Moriyama Y, Ide S, Nakamura K, Nakamoto T, Nomoto H, Akiyama Y, Miyazato Y, Suzuki T, Okuhama A, Kanda K, Wakimoto Y, Morioka S, Saito S, Yamamoto K, Ujiie M, Hayakawa K, Kustuna S, Yanagawa Y, Terada J, Takasaki J, Izumi S, Hojo M, Hinoshita F, Sugiyama M, Noiri E, Mizokami M, Ohmagari N, Sugiyama H.
 Crit Care Explor. 2020;2(8):e0170.
https://doi.org/10.1097/CCE.0000000000000170
（2020/7/31）

Possibility of transmission of severe acute respiratory syndrome coronavirus 2 in a tertiary care hospital setting: A case study.

Morioka S, Nakamura K, Iida S, Kutsuna S, Kinoshita N, Suzuki T, Suzuki T, Yamamoto K, Hayakawa K, Saito S, Ohmagari N. 
 Infection Prevention in Practice. 2020:100079.
https://doi.org/10.1016/j.infpip.2020.100079
（2020/7/30）

Detection of SARS-CoV-2 in hemodialysis effluent of patient with COVID-19 pneumonia, Japan.

Okuhama A, Ishikane M, Katagiri D, Kanda K, Nakamoto T, Kinoshita N, Nunose N, Fukaya T, Kondo I, Katano H, Suzuki T, Ohmagari N, Hinoshita F.
 Emerg Infect Dis. 2020;26(11):2758-2761.
https://doi.org/10.3201/eid2611.201956
（2020/7/30）

FDG-PET/CT images of COVID-19: a comprehensive review.

Minamimoto R, Hotta M, Ishikane M, Inagaki T.
 Glob Health Med. 2020.
https://doi.org/10.35772/ghm.2020.01056
（2020/7/20）

An Experience of PET/CT Examination in the Patient with a Recent History of COVID-19 Infection.

Saito K, Horikawa D, Takeuchi T, Mizunuma H, Yamada Y, Hironaka S, Kajiwara H, Hotta M, Matsunaga F, Minamimoto R.
 Japanese Journal of Radiological Technology. 2020;76(7):761-767. Japanese.
https://doi.org/10.6009/jjrt.2020_JJRT_76.7.761
（2020/7/20）

SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1I/D genotype.

Yamamoto N, Ariumi Y, Nishida N, Yamamoto R, Bauer G, Gojobori T, Shimotohno K, Mizokami M.
 Gene. 2020.
https://doi.org/10.1016/j.gene.2020.144944
（2020/7/3）

A familial cluster of severe coronavirus disease 2019 that required intubation of all family members.

Katsuno T, Suzuki M, Ishikane M, Kinoshita N, Tsukada A, Morita C, Kusaba Y, Sakamoto K, Yamaguchi Y, Tsujimoto Y, Hashimoto M, Terada J, Takasaki J, Izumi S, Okuhama A, Ide S, Moriyama Y, Matsuda K, Takamatsu Y, Mitsuya H, Hojo M, Sugiyama H.
 Infectious Diseases. 2020;52(10):755-758.
https://doi.org/10.1080/23744235.2020.1784999
（2020/7/2）